invites you to a
CPD evening with Dr. Aslam Amod
TOPIC: Insulin in Type II Diabetes
VENUE: Suncoast Conference Centre
Suncoast Boulevard, Durban Golden Mile
DATE: Wednesday 15 March 2017
CPD accredited Limited space available
RSVP:
ACCEPT or DECLINE
TIME: 18h30 – Networking and a quick meal 19H30 – Presentation 21h00 – Grab a dessert & coffee
by Wednesday, 8 March 2017
Dr. Aslam Amod, Chairperson of SEMDSA and the Association of Clinical Endocrinologists of South Africa
Reference: 1. IMS data. March 2017.
S3 Biosulin R( Solution for Injection): Each ml contains 100 IU of soluble biosynthetic human insulin. Reg. No.: 37 / 21.1 / 0670 S3 Biosulin N( Suspension for Injection): Each ml contains 100 IU of biosynthetic human isophane insulin. Reg. No.: 37 / 21.1 / 0671 S3 Biosulin L( Suspension for Injection): Each ml contains 100 IU of zinc biiosynthetic human insulin. Reg. No.: 37 / 21.1 / 0672 S3 Biosulin 30 / 70( Suspension for Injection): Each ml contains 100 IU of biphasic biosynthetic human insulin comprising of 30 % soluble insulin and 70 % isophane insulin. Reg. No.: 37 / 21.1 / 0673. For full prescribing information, refer to the respective package insert approved by the Medicines Regulatory Authority. Applicant: Dezzo Trading 392( Pty) Ltd. Co. Reg. No.: 2002 / 001923 / 07 Cnr. Birch Road and Bluegum Avenue, Anchorville, Lenasia, 1827. P. O. Box 725, Lawley, 1824. Tel: 011 857 2090. Fax: 086 664 6223. Customer Careline: 087 357 6000. ZA. BIOS. 05 05 / 2017
8 MAY 2017 | MEDICAL CHRONICLE